Hearing difficulty is an extremely common presenting complaint in medical practice. Management depends entirely on the underlying mechanism of the hearing loss, which is broadly categorized into two types:

• Conductive hearing loss occurs when sound energy is physically blocked from reaching the inner ear efficiently. This can be due to simple occlusion of the ear canal, perforation of the tympanic membrane (eardrum), or middle ear pathology, such as fluid (glue ear), infection, or erosion/fixation of the middle ear ossicles (bones). Many forms of conductive loss can be treated surgically (e.g., ventilation tubes or ossiculoplasty) or managed effectively with conventional hearing aids.

• Sensorineural hearing loss (SNHL) occurs when there is damage to the delicate inner ear structures (hair cells within the cochlea) or the auditory nerve. Common causes include aging (presbyacusis), noise exposure, infection, ischemia, or ototoxic drugs. While we cannot currently repair this damage medically or surgically, conventional hearing aids increase the sound energy reaching the ear to maximize remaining function.

For patients who derive insufficient benefit from traditional hearing aids, or who cannot wear them medically, advanced implantable hearing devices offer powerful alternatives.
 

Bone Conduction Hearing Systems

Bone conduction technology bypasses pathology in the outer or middle ear by transmitting sound vibrations directly through the skull bones to stimulate the functioning inner ear (cochlea). This is the same principle that allows tuning fork tests to work.

How They Work

Traditional bone conduction aids were often uncomfortable and inefficient, requiring a powerful oscillator pressed tightly against the scalp skin. A modern Bone Anchored Hearing Aid (BAHA) or active bone conduction implant circumvents these problems entirely.

As shown in Figure 1, a BAHA system utilizes an externally worn sound processor (image 4). This processor captures sound, converts it into mechanical vibrations, and transmits them through a surgical connection directly to the skull bones. In some systems (the original BAHA), this is a skin-penetrating titanium abutment; modern alternatives often use strong magnetic couplings under intact skin. Titanium is used because it osseointegrates, creating an exceptionally strong bond with the bone, allowing acoustic energy to transmit with minimal loss.

Indications

BAHAs are indicated for individuals with a conductive or mixed hearing loss who cannot wear—or do not benefit from—conventional acoustic aids. Specific scenarios include:

• Chronic Ear Discharge: Patients with chronic otitis media or previous mastoid surgery often find conventional ear molds cause their ear to become sweaty, leading to persistent infections. A BAHA leaves the ear canal completely open, avoiding this issue.

• Congenital Ear Malformations: Children born without an ear canal (aural atresia) but with healthy cochleae are excellent candidates, as the implant bypasses the outer ear blockage entirely. Bilateral fittings provide the best results.

• Otosclerosis: BAHAs are a safe and effective alternative for patients who choose not to undergo stapedectomy.

• Single-Sided Deafness (SSD): The BAHA is a highly effective treatment for unilateral profound sensorineural loss (e.g., after acoustic neuroma surgery). The device captures sound from the deaf side and conducts the vibrations across the skull to stimulate the contralateral (healthy) cochlea, outperforming conventional CROS aids.

Middle Ear Implants (MEIs)

Middle ear implants provide direct mechanical stimulation to the middle ear ossicles or the round window, offering natural sound amplification without occluding the ear canal.

How They Work

The most established device is the Vibrant Soundbridge (a partially implantable system), illustrated in Figure 2. It consists of an external audio processor worn magnetically on the scalp and an internally implanted receiver/stimulator (VORP™). This receiver drives a tiny, sophisticated electromagnetic transducer, known as the Floating Mass Transducer (FMT).

The FMT is surgically attached directly to one of the ossicles (typically the incus, as shown) or to the round window membrane. Sound is captured by the processor, digitized, and transmitted through the skin to the receiver, which then activates the FMT, vibrating the inner ear structures.

Indications & Advantages

Middle ear implants are typically suitable for adults and children (over 18 months, depending on specific device approval) with mild-to-profound sensorineural, conductive, or mixed hearing loss, particularly within the range shown in Figure 3.

Key advantages over conventional aids include:

• Natural Sound: Sounds often seem clearer and more natural without acoustic distortion.

• No Feedback: There is no ear mold, dramatically reducing feedback whistling, allowing for higher, clean amplification.

• Open Ear Canal: This eliminates the "occlusion effect" (the echo of one's own voice) and humidity, making it ideal for patients prone to ear canal infections.

Cochlear Implants (CIs)

Cochlear implants are the gold standard treatment for individuals with severe-to-profound sensorineural hearing loss who derive minimal benefit from the most powerful conventional hearing aids. These devices are the first that attempt to replace a human sense (hearing) by electrically stimulating the auditory nerve.

How They Work

The basic design, seen in Figure 4, involves an externally worn speech processor (often looking like a large hearing aid) and an internal receiver/stimulator package implanted under the scalp skin. A transmitting coil (headpiece) transfers coded signals across the skin to the receiver, which connects to a flexible electrode array surgically inserted into the scala tympani of the cochlea.

As demonstrated in Figure 5, sound is detected by microphones on the Speech Processor and digitized. These digital signals are sent across the scalp to the internal Receiver/Stimulator, which generates precise electrical pulses. These pulses are delivered to the Electrode Array deep within the cochlea, directly stimulating the bipolar neurons of the auditory nerve.

Candidacy & Current Guidelines

Cochlear implantation candidacy is determined by formal evaluation from a specialist Cochlear Implant Unit. The clinical threshold has expanded as technology and outcomes improve. Key candidate profiles include:

1. Post-lingually Deafened: Adults or children who acquire speech and language and then lose their hearing. They often achieve excellent outcomes.

2. Pre-lingually Deafened Children: Children born deaf or deafened before acquiring speech can do extremely well if implanted in time. The central auditory pathways require stimulation for maturation (neuroplasticity). Early intervention is critical; optimal results are obtained if children are implanted before age 2, and after age 5 outcomes decline.

3. Severe-to-Profound Loss (NICE TA561 Guidelines): Current UK guidelines define candidates as individuals with unaided hearing thresholds [endif]--> at two or more frequencies ([endif]-->), who show inadequate speech perception scores with optimized hearing aids.

4. Intact Auditory Nerve: The auditory nerve must be present on the side to be implanted; if it is not, an Auditory Brainstem Implant may be required.

5. Single-Sided Deafness (SSD): CIs are now routinely utilized for SSD to restore directional hearing and speech perception in noisy environments, outperforming bone conduction aids in binaural listening tests.

6. Electro-Acoustic Stimulation (EAS / Hybrid): Short-array hybrid implants are available for patients with preserved low-frequency hearing but profound high-frequency loss, combining acoustic and electrical stimulation.

Ongoing Clinical Practice

Cochlear implant results have revolutionized deaf communication. While a great deal of rehabilitation and programming ("mapping") is required, deaf children can now develop normal speech and language, and deaf adults can often carry on telephone conversations with strangers. Routine clinical practice now includes:

• Bilateral Implantation: Bilateral simultaneous or sequential implantation is now standard for all suitable children (NICE 2019 guidelines) to provide directional hearing. Adults typically receive unilateral implants, although sequential bilateral implants are increasingly common in specific clinical pathways.

• Meningitis Prophylaxis: There is a slightly increased risk of meningitis after any cochlear implant surgery. All candidates are therefore required to receive pneumococcal and other vaccines prior to implantation to minimize this risk.

Auditory Brainstem Implants (ABIs)

In a rare set of clinical scenarios, such as bilateral acoustic neuroma tumors in Neurofibromatosis Type 2 (NF2) or severe auditory nerve aplasia, the auditory nerve itself is non-functional or absent. In these cases, electrical stimulation at the cochlear level cannot be transmitted to the brain.

An Auditory Brainstem Implant bypasses both the cochlea and the auditory nerve, delivering coded electrical signals via a multi-channel paddle electrode placed directly onto the cochlear nucleus complex in the brainstem. While ABIs do not restore natural hearing or complex music perception, they provide crucial environmental sound awareness and timing cues that dramatically enhance a patient's reliance on lip-reading.

Conclusions

Advanced implantable hearing devices have transformed the landscape of otology.

• Patients with mild-to-moderate conductive or mixed loss who cannot wear traditional aids may be helped by a BAHA, especially in cases of chronic ear discharge.

• Patients with mild-to-severe sensorineural or mixed loss who cannot tolerate ear mold occlusion can benefit significantly from a Middle Ear Implant.

• Patients with severe-to-profound sensorineural loss who derive inadequate benefit from acoustic amplification can regain meaningful access to sound and spoken language with a Cochlear Implant, with early intervention in children being paramount.